OrganiGram Holdings Inc. faced a sharp decline today, with shares dropping 7.30% to close at CA$1.27.
In a challenging trading session, OrganiGram Holdings Inc. (OGI.TO) saw its stock price fall significantly, reflecting ongoing struggles in the cannabis sector. This decline raises concerns for investors about the company's future performance amidst a volatile market.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
OrganiGram Holdings Inc
OGI.TO
OGI.TO
OrganiGram Holdings Inc
WealthAwesomeMarket cap
$192.86M
52W high
$3.09
52W low
$1.24
1W change
-8.96%
Beta
1.85
Analyst Price Targets
Based on analyst covering OGI
Wall Street analysts forecast OGI stock price to rise 134.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.98
+134.6% Upside
Current Price
C$1.27
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on OGI's historical volatility
30-Day Vol
41.1%
Annualized
90-Day Vol
54.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.06
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$1.20 | C$1.04 โ C$1.38 |
| 60 trading days | C$1.13 | C$0.92 โ C$1.38 |
| 90 trading days | C$1.06 | C$0.83 โ C$1.36 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should closely monitor OrganiGram's operational strategies and market positioning as the cannabis industry continues to evolve. Today's drop may indicate deeper issues that could affect long-term profitability.
OrganiGram's Stock Drops 7.30% in One Day
With a market cap of CA$178.78 million, OrganiGram's recent performance highlights the challenges faced by cannabis companies in maintaining investor confidence.
Bull case
If OrganiGram can successfully integrate its recent acquisitions and tap into expanding markets, it might recover and offer significant returns in the long run.
Bear case
Ongoing operational losses and market volatility could slow OrganiGram's recovery, leading to further declines and potential losses for investors.
Market Reaction
The decline in OrganiGram's stock price reflects broader concerns in the cannabis market, where companies are grappling with regulatory hurdles and competitive pressures. Investors are reacting to these challenges, leading to today's significant drop.
Company Performance
Despite recent acquisitions aimed at expanding its market share, OrganiGram has struggled with profitability. With a profit margin of -9.2%, the company faces uphill battles in achieving sustainable growth. Investors should consider these financial metrics when evaluating the stock's potential.
Looking Ahead
As OrganiGram navigates its current challenges, investors are advised to keep an eye on upcoming earnings reports and strategic developments. The company's ability to adapt to market conditions will be crucial for its recovery and future performance. For more insights, check out the latest updates on OGI.TO.
Advertisement
